[TET2 mutations have recently been described in approximately 29% of patients with systemic mastocytosis, but their pathogenetic or treatment relevance is unknown.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE